Results 211 to 220 of about 560,362 (316)
Platelet FcɣRIIa Expression Refines Clinical Risk Assessment After Myocardial Infarction
ABSTRACT Background In patients with myocardial infarction (MI), quantifying expression of platelet FcɣRIIa (pFCG) stratifies risk of subsequent MI, stroke, and death. Aims Assess the prognostic implications of clinical risk alone and in combination with the pFCG test.
David J. Schneider +9 more
wiley +1 more source
The Clinical Significance and Prognostic Value of Inflammatory Hematological Indices in Young Patients with Coronary Artery Disease. [PDF]
Sun J +7 more
europepmc +1 more source
Pathophysiologic Consequences of Early Coarctation Stenting in a Longitudinal Porcine Model
ABSTRACT Background Novel stent technologies offer early intravascular treatment options for coarctation (COA). Mid‐to‐long‐term cardiovascular responses to early COA stent interventions are undefined. Aims We studied a porcine model of COA, with and without early stent implantation with serial dilation to adult aortic diameters, aiming to define ...
Leah M. Gober +7 more
wiley +1 more source
Risk factors for cardiac death in women with coronary artery disease. [PDF]
King IS +11 more
europepmc +1 more source
RNA-Based Therapies for Hypercholesterolemia and Coronary Artery Disease. [PDF]
Lopez Mendoza MJ +5 more
europepmc +1 more source
Protective Effect of Phytic Acid in Cardiovascular Diseases: A Systematic Review
ABSTRACT Cardiovascular diseases (CVDs) are a cluster of ailments that impact the heart and blood vessels and are a primary public health problem of mortality on a global scale. Phytic acid, a dietary constituent frequently present in foods like seeds, has been linked to many pharmacological attributes, including anti‐cancer, antioxidant, anti ...
Marta M. S. de Freitas Almeida +7 more
wiley +1 more source
Ezetimibe vs Inclisiran in Coronary Artery Disease and Hyperlipidemia: A Propensity-Matched Analysis. [PDF]
Akbar UA +7 more
europepmc +1 more source
CYP2C19 and CYP3A4 contribute to clopidogrel bioactivation. CYP2C19 no‐function alleles diminish clopidogrel's antiplatelet effects and clinical effectiveness. Coadministration of either a CYP2C19 or a CYP3A4 inhibitor may also reduce clopidogrel's antiplatelet effects and lead to phenoconversion in patients without a CYP2C19 no‐function allele (normal/
Danwei Shao +8 more
wiley +1 more source

